Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1953 16
1954 23
1955 21
1956 59
1957 158
1958 116
1959 70
1960 1
1963 1
1964 4
1965 127
1966 169
1967 150
1968 133
1969 125
1970 113
1971 145
1972 139
1973 106
1974 80
1975 99
1976 94
1977 92
1978 81
1979 87
1980 106
1981 82
1982 86
1983 88
1984 85
1985 110
1986 91
1987 57
1988 49
1989 58
1990 60
1991 61
1992 40
1993 57
1994 70
1995 81
1996 66
1997 59
1998 102
1999 74
2000 72
2001 69
2002 81
2003 68
2004 127
2005 243
2006 204
2007 247
2008 250
2009 268
2010 249
2011 309
2012 403
2013 533
2014 613
2015 711
2016 699
2017 699
2018 700
2019 398
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

9,763 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S. Miklos D, et al. Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18. Blood. 2017. PMID: 28924018 Free PMC article. Clinical Trial.
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
Verstovsek S, Mesa RA, Gotlib J, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner EO, Lyons RM, Paquette R, Raza A, Jones M, Kornacki D, Sun K, Kantarjian H; COMFORT-I investigators. Verstovsek S, et al. J Hematol Oncol. 2017 Feb 22;10(1):55. doi: 10.1186/s13045-017-0417-z. J Hematol Oncol. 2017. PMID: 28228106 Free PMC article. Clinical Trial.
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, Gitlin SD, Kaminski M, Cusick A, Phillips T, Sood S, Talpaz M, Quiery A, Boonstra PS, Wilcox RA. Ahmed A, et al. Lancet Haematol. 2019 Dec;6(12):e630-e637. doi: 10.1016/S2352-3026(19)30156-5. Epub 2019 Sep 16. Lancet Haematol. 2019. PMID: 31537486 Clinical Trial.
[Fomepizole].
Endo Y. Endo Y. Chudoku Kenkyu. 2015 Mar;28(1):31-6. Chudoku Kenkyu. 2015. PMID: 26399012 Japanese. No abstract available.
The therapeutic voyage of pyrazole and its analogs: A review.
Khan MF, Alam MM, Verma G, Akhtar W, Akhter M, Shaquiquzzaman M. Khan MF, et al. Eur J Med Chem. 2016 Sep 14;120:170-201. doi: 10.1016/j.ejmech.2016.04.077. Epub 2016 May 10. Eur J Med Chem. 2016. PMID: 27191614 Review.
9,763 results
Jump to page
Feedback